Picture of Zydus Lifesciences logo

ZYDUSLIFE — Zydus Lifesciences News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Brief: Zydus Lifesciences Receives Final USFDA Approval For Dapagliflozin Tablets

April 8 (Reuters) - Zydus Lifesciences Ltd ZYDU.NS:

RECEIVES FINAL USFDA APPROVAL FOR DAPAGLIFLOZIN TABLETS

Source text: ID:nNSE7lyqfm

Further company coverage: ZYDU.NS

 ((Reuters.Briefs@thomsonreuters.com;;))

Recent news on Zydus Lifesciences

See all news